Search - tctmd.com

Displaying 21 - 31 of 31

Sort: Relevancy | Date

Presentation TCT 2014

Are GP IIb/IIIa Inhibitors Still Useful?

Presenter: Marco Valgimigli

September 13, 2014

Presentation Fellows 2014

Navigating the New Oral Anticoagulants and How to Deal with Triple Therapy

Presenter: George Dangas

April 12, 2014

Presentation Fellows 2014

Antithrombin Pharmacology for the Interventionalist

Presenter: Sunil Rao

April 12, 2014

Presentation Fellows 2013

Platelet Function Testing, Genomics, and Antiplatelet Agent Resistance

Presenter: Matthew Price

April 16, 2013

Presentation Fellows 2013

Antiplatelet Therapy for the Interventionalist

Presenter: Matthew Price

April 16, 2013

$Unfractionated, Low Molecular Weight Heparins, and Xa Inhibitors in ACS and PCI, With and Without GP IIb/IIIa Inhibitors$

Presentation Fellows 2012

Unfractionated, Low Molecular Weight Heparins, and Xa Inhibitors in ACS and PCI, With and Without GP IIb/IIIa Inhibitors

Presenter: George Dangas

April 22, 2012

Presentation Fellows 2012

Platelet Function Testing, Genomics, and Antiplatelet Agent Resistance

Presenter: Deepak Bhatt

April 22, 2012

Presentation Fellows 2012

Oral Antithrombin and Xa Inhibitors for ACS and PCI

Presenter: Michael Ezekowitz

April 22, 2012

Presentation Fellows 2012

Oral Antiplatelet Agents in PCI and ACS

Presenter: Roxana Mehran

April 22, 2012

Presentation Fellows 2012

Bivalirudin in ACS and PCI

Presenter: Gregg Stone

April 22, 2012

CME

Advertisement

Are GP IIb/IIIa Inhibitors Still Useful?

Navigating the New Oral Anticoagulants and How to Deal with Triple Therapy

Antithrombin Pharmacology for the Interventionalist

Platelet Function Testing, Genomics, and Antiplatelet Agent Resistance

Antiplatelet Therapy for the Interventionalist

Unfractionated, Low Molecular Weight Heparins, and Xa Inhibitors in ACS and PCI, With and Without GP IIb/IIIa Inhibitors

Platelet Function Testing, Genomics, and Antiplatelet Agent Resistance

Oral Antithrombin and Xa Inhibitors for ACS and PCI

Oral Antiplatelet Agents in PCI and ACS

Bivalirudin in ACS and PCI

Changing Course with Anticoagulation in Secondary Prevention of CAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content